Section 1 Short title
This Act may be cited as the “MCM PRV Reauthorization Act”.
MCM PRV Reauthorization Act
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to extend a priority review program to encourage treatments for agents that present national security threats.
Sec. 2 Extension of priority review to encourage treatments for agents that present national security threats
Section 565A(g) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–4a(g)) is amended by striking “2023” and inserting “2033”.